Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

ClinicalTrials.gov ID: NCT01456611

Public ClinicalTrials.gov record NCT01456611. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of Diclofenac Sodium 1% Gel (Anchen Pharmaceuticals, Inc.) With Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis) in Patients With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the clinical equivalence and safety of the Test formulation of diclofenac sodium topical gel 1% (Anchen Pharmaceuticals, Inc.) compared to the marketed formulation Voltaren® Gel (diclofenac sodium topical gel) 1% (Novartis) in patients with osteoarthritis of the knee. The efficacy of both the Test and Reference formulations will also be compared to the Placebo gel to determine Superiority.

Study identification

NCT ID
NCT01456611
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Anchen Pharmaceuticals, Inc
Industry
Enrollment
749 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2011 (Type not available)
Primary completion
Apr 2012 (Actual)
Completion
Apr 2012 (Actual)
Last update posted
Jul 12, 2012

2011 – 2012

United States locations

U.S. sites
57
U.S. states
20
U.S. cities
57
Facility City State ZIP Site status
Novum Investigator Site Birmingham Alabama — —
Novum Investigator Site Huntsville Alabama — —
Novum Investigator Site Chandler Arizona — —
Novum Investigator Site Mesa Arizona — —
Novum Investigator Site Phoenix Arizona — —
Novum Investigator Site Tuscon Arizona — —
Novum Investigator Site Little Rock Arkansas — —
Novum Investigator Site Anaheim California — —
Novum Investigator Site Carmichael California — —
Novum Investigator Site Garden Grove California — —
Novum Investigator Site Long Beach California — —
Novum Investigator Site Sacramento California — —
Novum Investigator Site San Diego California — —
Novum Investigator Site Stock Bridge California — —
Novum Investigator Site Denver Colorado — —
Novum Investigator Site Norwalk Connecticut — —
Novum Investigator Site Stamford Connecticut — —
Novum Investigator Site Adventura Florida — —
Novum Investigator Site Bookville Florida — —
Novum Investigator Site Bradenton Florida — —
Novum Investigator Site Daytona Beach Florida — —
Novum Investigator Site Hialeah Florida — —
Novum Investigator Site Jupiter Florida — —
Novum Investigator Site Miami Florida — —
Novum Investigator Site Ormond Beach Florida — —
Novum Investigator Site Pinellas Park Florida — —
Novum Investigator Site Sarasota Florida — —
Novum Investigator Site St. Petersburg Florida — —
Novum Investigator Site Tampa Florida — —
Novum Investigator Site Marietta Georgia — —
Novum Investigator Site Sandy Springs Georgia — —
Novum Investigator Site Lexington Kentucky — —
Novum Investigator Site New Orleans1 Louisiana — —
Novum Investigator Site Hollywood Maryland — —
Novum Investigator Site Billings Montana — —
Novum Investigator Site Henderson Nevada — —
Novum Investigator Site Cary North Carolina — —
Novum Investigator Site Charlotte North Carolina — —
Novum Investigator Site Hickory North Carolina — —
Novum Investigator Site High Point North Carolina — —
Novum Investigator Site Raleigh North Carolina — —
Novum Investigator Site Salisbury North Carolina — —
Novum Investigator Site Wilmington North Carolina — —
Novum Investigator Site Winston-Salem North Carolina — —
Novum Investigator Site Cleveland Ohio — —
Novum Investigator Site Columbus Ohio — —
Novum Investigator Site Beavercreek Oklahoma — —
Novum Investigator Site Norman Oklahoma — —
Novum Investigator Site Duncansville Pennsylvania — —
Novum Investigator Site Chattanooga Tennessee — —
Novum Investigator Site Houston Texas — —
Novum Investigator Site Longview Texas — —
Novum Investigator Site San Antonio Texas — —
Novum Investigator Site Sugar Land Texas — —
Novum Investigator Site Charlottesville Virginia — —
Novum Investigator Site Midlothian Virginia — —
Novum Investigator Site Newport News Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01456611, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2012 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01456611 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →